Cytokinetics (CYTK) Tops Q4 EPS by 4c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus
Go back to Cytokinetics (CYTK) Tops Q4 EPS by 4c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 67.59 +0.03 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.56 | 52 Week High | $13.18 | |||
| Open | $68.07 | 52 Week Low | $6.00 | |||
| Day High | $69.56 | P/E | N/A | |||
| Day Low | $67.48 | EPS | $-1.24 | |||
| Volume | 2,388,591 | |||||
